Literature DB >> 11278623

Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.

A M Belkin1, S S Akimov, L S Zaritskaya, B I Ratnikov, E I Deryugina, A Y Strongin.   

Abstract

Cell invasion requires cooperation between adhesion receptors and matrix metalloproteinases (MMPs). Membrane type (MT)-MMPs have been thought to be primarily involved in the breakdown of the extracellular matrix. Our report presents evidence that MT-MMPs in addition to the breakdown of the extracellular matrix may be engaged in proteolysis of adhesion receptors on tumor cell surfaces. Overexpression of MT1-MMP by glioma and fibrosarcoma cells led to proteolytic degradation of cell surface tissue transglutaminase (tTG) at the leading edge of motile cancer cells. In agreement, structurally related MT1-MMP, MT2-MMP, and MT3-MMP but not evolutionary distant MT4-MMP efficiently degraded purified tTG in vitro. Because cell surface tTG represents a ubiquitously expressed, potent integrin-binding adhesion coreceptor involved in the binding of cells to fibronectin (Fn), the proteolytic degradation of tTG by MT1-MMP specifically suppressed cell adhesion and migration on Fn. Reciprocally, Fn in vitro and in cultured cells protected its surface receptor, tTG, from proteolysis by MT1-MMP, thereby supporting cell adhesion and locomotion. In contrast, the proteolytic degradation of tTG stimulated migration of cells on collagen matrices. Together, our observations suggest both an important coreceptor role for cell surface tTG and a novel regulatory function of membrane-anchored MMPs in cancer cell adhesion and locomotion. Proteolysis of adhesion proteins colocalized with MT-MMPs at discrete regions on the surface of migrating tumor cells might be controlled by composition of the surrounding ECM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278623     DOI: 10.1074/jbc.M010135200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  MT1-MMP-mediated basement membrane remodeling modulates renal development.

Authors:  Karen S Riggins; Glenda Mernaugh; Yan Su; Vito Quaranta; Naohiko Koshikawa; Motoharu Seiki; Ambra Pozzi; Roy Zent
Journal:  Exp Cell Res       Date:  2010-08-19       Impact factor: 3.905

Review 3.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

4.  Antagonistic enzymes may generate alternate phase transitions leading to ephemeral gels.

Authors:  Sébastien Giraudier; Véronique Larreta-Garde
Journal:  Biophys J       Date:  2007-04-27       Impact factor: 4.033

5.  Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2.

Authors:  Cristina Antonella Nadalutti; Ilma Rita Korponay-Szabo; Katri Kaukinen; Martin Griffin; Markku Mäki; Katri Lindfors
Journal:  Cell Mol Life Sci       Date:  2013-08-28       Impact factor: 9.261

6.  Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.

Authors:  Chi Hua Sarah Lin; Jun Chen; Zhongtao Zhang; Gail V W Johnson; Arthur J L Cooper; Julianne Feola; Alexander Bank; Jonathan Shein; Heli J Ruotsalainen; Taina A Pihlajaniemi; Michael S Goligorsky
Journal:  Kidney Int       Date:  2016-04-14       Impact factor: 10.612

7.  A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.

Authors:  Che-Yi Chou; Andrew J Streets; Philip F Watson; Linghong Huang; Elisabetta A M Verderio; Timothy S Johnson
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

8.  Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7).

Authors:  Vladislav S Golubkov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

10.  Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression.

Authors:  Carine Nyalendo; Hervé Sartelet; Stéphane Barrette; Shigeru Ohta; Denis Gingras; Richard Béliveau
Journal:  BMC Cancer       Date:  2009-12-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.